DoveBid adds to US IPO gloom

DoveBid, an online auctioneer that was due to go public this week, has pulled its $54m (€54.7m) flotation, following on from one of the the bleakest quarters ever for initial public offerings in the US.

Last week LipoScience, a medical technology company long tipped to reopen the US market, postponed its $75m offering led by Merrill Lynch. JP Morgan was leading the DoveBid IPO.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump